Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmaceutical Medicine|May 4, 2026
Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive AnalysisLaura Fankhauser, Franca Ligas, Giovanni Lesa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2024
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational SymposiumJason Fangusaro, Robert A Avery, Michael J Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancerSteven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.
European Journal of Cancer (Oxford, England : 1990)|September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug AdministrationAndrew D J Pearson, Elly Barry, Yael P Mossé, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerAndrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
Pageof 3